Reine Allan — SEC Form 4 filings
SEC reporting owner CIK 1714023. 10 Form 4 filings on record with FilingPulse; latest filed 2026-02-27.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-17 to 2026-02-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 125,000 shares, $147,150 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 125,000 shares @ $1.18 ($147,150) in Prime Medicine, Inc., filed 2025-05-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Prime Medicine, Inc. (PRME) | Chief Executive Officer, Director | 9 | 1 leg · 125,000 sh · $147,150 | — | 9 |
| Foghorn Therapeutics Inc. (FHTX) | Chief Financial Officer | 1 | — | — | — |
Form 4 filings — Reine Allan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-27 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 1,300,000 (derivative) @ $0 | EDGAR |
| 2025-08-05 | 4 | Prime Medicine, Inc. (PRME) | Disposition to issuer (D): 850,000 (derivative) · Grant/award (A): 850,000 (derivative) | EDGAR |
| 2025-05-22 | 4 | Prime Medicine, Inc. (PRME) | Purchase (P): 125,000 @ $1.18 | EDGAR |
| 2025-05-19 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 2,000,000 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2024-12-09 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | Foghorn Therapeutics Inc. (FHTX) | Holdings only — no transactions reported | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1714023 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →